MedPath

Keppra

Brand Name: Keppra

Generic Name: Levetiracetam

Active
Registration Number

DR-XY36632

Dosage Form

Concentrate For Solution For IV Infusion

Issuance Date

July 1, 2024

Expiry Date

September 10, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg/5 mL
PackagingType I Clear and colorless Glass Vial x 5 mL with orange flip-off seal in plastic tray x 5’s (Box of 10's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antiepileptic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LevetiracetamActive
Monograph: Levetiracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform